The Impact of a Web-based Patient Decision Aid for Women Considering Breast Reconstruction (TANGO)

June 3, 2022 updated by: The Netherlands Cancer Institute

The Impact of a Web-based Decision Aid for Women Considering Breast Reconstruction: a Randomized Controlled Trial

This study evaluates the impact of an online patient decision aid on the process of decision making regarding breast reconstruction and the decision quality in women with breast cancer undergoing mastectomy and considering immediate breast reconstruction. Half of participants will receive care as usual and access to the online decision aid, while the other half will receive care as usual including a standard information leaflet.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Rationale: In the Netherlands, of the approximately 15,000 women who are diagnosed with breast cancer each year, about 40% undergo mastectomy. A wide variety of breast reconstructive methods are offered to these women. In most cases, there is no clear medical recommendation on which procedure is the best. Decisions for breast surgery and reconstruction are frequently made during an emotionally burdensome and restricted timeframe. Women may find it hard to make a decision for the type of surgery and reconstruction, some feel that the decision is hurried and uninformed, and many have some degree of regret about their decision at a later date. To support women in making a well-informed decision about breast reconstruction, an online patient decision aid (pDA) has been developed.

Objective: The primary objective of the study is to evaluate the impact of the use of the online pDA on the process of decision making regarding breast reconstruction and the decision quality. The secondary objective of the study is to evaluate the impact of the use of the online pDA on patient reported health outcomes, to identify possible moderators of the effect, and to investigate the cost-effectiveness.

Hypotheses: It is hypothesized that the online pDA, as compared to usual care, will improve the decision making process about breast reconstruction (i.e. leads to less decisional conflict, higher satisfaction with information, higher levels of preparedness for decision making and higher perceived levels of shared decision making) and that it will improve the decision quality (i.e. leads to higher levels of knowledge about breast reconstruction and lower levels of regret).

Study design: A multicenter randomized controlled trial (RCT) will be performed in eight hospitals. All consenting participants will be randomized into one of the two study arms (intervention group or control group). Women in both groups will be invited to complete questionnaires at baseline (i.e. before randomization), 1 week after consultation with a plastic surgeon and 3 and 12 months after breast surgery.

Study population: 250 women will participate.

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amersfoort, Netherlands
        • Meander Medical Center
      • Amsterdam, Netherlands
        • Netherlands Cancer Institute
      • Amsterdam, Netherlands
        • Medical Center Slotervaart
      • Delft, Netherlands
        • Reinier de Graaf Gasthuis
      • Leeuwarden, Netherlands
        • Medical center Leeuwarden
      • Rotterdam, Netherlands
        • Erasmus Medical Center
      • Rotterdam, Netherlands
        • Franciscus Gasthuis & Vlietland
      • Utrecht, Netherlands
        • University Medical Center Utrecht

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • female (≥18 years);
  • diagnosed with breast cancer or carcinoma in situ;
  • will be treated with mastectomy and is eligible for immediate breast reconstruction;
  • is referred to a plastic surgeon (consultation takes place ≥3 working days after study invitation);
  • has internet access and sufficient computer skills;
  • is able to read and speak the Dutch language.

Exclusion Criteria: None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group
Care as usual and an online patient decision aid
An online, interactive tool that can be used to prepare for consultation with a plastic surgeon which contains evidence-based information about breast reconstruction options, the pros and cons of the options, value clarification exercises and patient narratives. It results in a summary sheet with patients' personal values and questions that can be discussed during consultation with a plastic surgeon.
Other Names:
  • Breast Reconstruction Decision Aid
No Intervention: control group
Care as usual with a standard information leaflet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decisional conflict
Time Frame: 1 week after consultation with a plastic surgeon (T1)
decisional conflict scale (DCS); the DCS consists of a total score and five subscales (uncertainty, feeling informed, feeling clear about values, feeling supported and effective decision-making). It consists of 16 items which are rated on a 5-point Likert-type scale (strongly agree- strongly disagree). Scores range from 0 - 100, with higher scores indicating more decisional conflict.
1 week after consultation with a plastic surgeon (T1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decisional conflict
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
decisional conflict scale (DCS); the DCS consists of a total score and five subscales (uncertainty, feeling informed, feeling clear about values, feeling supported and effective decision-making). It consists of 16 items which are rated on a 5-point Likert-type scale (strongly agree- strongly disagree). Scores range from 0 - 100, with higher scores indicating more decisional conflict.
3 months after surgery (T2); 12 months after surgery (T3)
decision regret
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
decision regret scale (DRS); the DRS consists of 5 items, rated on a 5 point Likert-type scale (strongly agree - strongly disagree). Scores range from 0 - 100, with higher scores indicating higher levels of regret.
3 months after surgery (T2); 12 months after surgery (T3)
knowledge about breast reconstruction
Time Frame: 1 week after consultation with plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)
study-specific questionnaire consisting of 10 items (true/false/I don't know)
1 week after consultation with plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)
preparedness for decision making
Time Frame: 1 week after consultation with a plastic surgeon (T1)
preparation for decision making scale; 10 items, rated on a 5-point Likert-type scale (Not at all - a great deal). Scores range from 0 - 100, with higher scores indicating higher perceived level of preparation for decision making.
1 week after consultation with a plastic surgeon (T1)
satisfaction with information
Time Frame: 1 week after consultation with plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)
three study-specific questions (a. How satisfied are you with the information about breast reconstruction? (5 point Likert-scale: not at all - very satisfied), b. Did you miss information? (yes/no), and c. Would you have preferred less information? (yes/no)). The subsample of women who opted for breast reconstruction will also complete the Satisfaction with Information-subscale of the Breast-Q (14 items, 4 point Likert-type scale, very dissatisfied - very satisfied, scores range from 0 -100, with higher scores indicating higher levels of satisfaction with information).
1 week after consultation with plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)
patient's perception of shared decision making
Time Frame: 1 week after consultation with a plastic surgeon (T1)
shared decision making questionnaire (SDM-Q-9); the SDM-Q-9 consists of 9 items, rated on a 6 point Likert-type scale (completely disagree - completely agree). The sum of all items (score between 0 - 45) will be multiplied by 20/9 to transform scores to range from 0 -100, where 0 indicates the lowest possible level of shared decision making and 100 indicates the highest extent of shared decision making.
1 week after consultation with a plastic surgeon (T1)
satisfaction with plastic surgeon
Time Frame: 1 week after consultation with plastic surgeon (T1)
The subscale Satisfaction with Surgeon of the Breast-Q consists of 12 items, rated on a 4 point Likert-type scale (completely disagree - completely agree). Scores range from 0 - 100.
1 week after consultation with plastic surgeon (T1)
actual choice
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
actual choice about breast reconstruction (self-reported and verified against patients' medical records)
3 months after surgery (T2); 12 months after surgery (T3)
satisfaction with outcome
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
The Breast-Q subscale Satisfaction with Breast measures body image in terms of a woman's satisfaction with her breasts. It consists of 4 to 16 items (depending on the type of surgery), rated on a 4 point Likert-type scale (very dissatisfied - very satisfied). The subsample of women who opted for breast reconstruction also completes the Breast-Q subscale Satisfaction with Breast Outcome (7 items, 3 point Likert-type scale (disagree - completely agree)), measuring a woman's overall appraisal of the outcome of her breast surgery. For both subscales, scores range from 0 -100, with higher scores indicating higher satisfaction.
3 months after surgery (T2); 12 months after surgery (T3)
body image
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
Subscale Body Image of the EORTC QLQ-BR23 (4 items, 4 point likert-type scale (not at all - very much), scores range from: 0-100 , a higher score is better.
3 months after surgery (T2); 12 months after surgery (T3)
sexual functioning
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
Subscales of Sexual Functioning (2 items) and Sexual Enjoyment (1 item) of the EORTC-QLQ BR23. Both subscale are rated on a 4 point Likert-type scale (not at all - very much). Scores range from 0-100, a higher score is better.
3 months after surgery (T2); 12 months after surgery (T3)
breast symptoms
Time Frame: 3 months after surgery (T2); 12 months after surgery (T3)
Subscale Breast Symptoms (4 items, 4 point Likert-type scale, not at all - very much) of the EORTC QLQ-BR23. Scores range from 0-100, a higher score is worse.
3 months after surgery (T2); 12 months after surgery (T3)
anxiety
Time Frame: 1 week after consultation with a plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)
The short-form of the state scale of the spielberger state-trait anxiety inventory (STAI), consisting of 6 items, rated on a 4 point Likert-type scale (not at all - very much). Scores range from 20 - 80, with higher scores indicating higher levels of anxiety.
1 week after consultation with a plastic surgeon (T1); 3 months after surgery (T2); 12 months after surgery (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eveline MA Bleiker, Professor, The Netherlands Cancer Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2017

Primary Completion (Actual)

May 28, 2019

Study Completion (Actual)

October 8, 2020

Study Registration Dates

First Submitted

December 17, 2018

First Submitted That Met QC Criteria

December 31, 2018

First Posted (Actual)

January 2, 2019

Study Record Updates

Last Update Posted (Actual)

June 6, 2022

Last Update Submitted That Met QC Criteria

June 3, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • NKI 2014-7031
  • A6C/NKI 2014-7031 (Other Grant/Funding Number: Dutch Cancer Society)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe